Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Australian Clinical Labs Ltd
ACLCurrent price
3.54 AUD
-0.01 AUD (-0.28%)
Last closed
3.58 AUD
Company
www.clinicallabs.com.au
ISIN
AU0000148496
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
Australian Securities Exchange
Capitalization
739 049 414 AUD
Yield for 12 month
+34.60 %
1Y
3Y
5Y
10Y
15Y
ACL
Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia. Address: 1868-1892 Dandenong Road, Clayton, VIC, Australia, 3168
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5.44 AUDP/E ratio
30.0833Dividend Yield
3.5 %Current Year
+700 221 029 AUD
Last Year
+702 632 162 AUD
Current Quarter
+182 281 546 AUD
Last Quarter
+182 281 546 AUD
Current Year
+140 558 310 AUD
Last Year
+574 631 025 AUD
Current Quarter
+69 078 666 AUD
Last Quarter
+69 078 666 AUD
Key Figures ACL
1 year
3 years
5 years
10 years
EBITDA
77 468 895 AUD
Operating Margin TTM
PE Ratio
30.0833
Return On Assets TTM
6.67 %
PEG Ratio
–
Return On Equity TTM
13.84 %
Wall Street Target Price
5.44 AUD
Revenue TTM
706 962 046 AUD
Book Value
0.9 AUD
Revenue Per Share TTM
Dividend Share
0.12 AUD
Quarterly Revenue Growth YOY
6.6 %
Dividend Yield
3.5 %
Gross Profit TTM
254 229 711 AUD
Earnings per share
0.12 AUD
Diluted Eps TTM
0.12 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
84.6 %
Profit Margin
3.44 %
Dividend Analytics ACL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
210 %Dividend History ACL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.18
Ex Dividend Date
04.09.2024
Forward Annual Dividend Yield
5 %
Last Split Factor
–
Payout Ratio
83.33 %
Last Split Date
–
Dividend Date
–
Stock Valuation ACL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
30.0833
Forward PE
19.4932
Enterprise Value Revenue
1.4625
Price Sales TTM
1.0454
Enterprise Value EBITDA
5.9459
Price Book MRQ
4.0893
Financials ACL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ACL
For 52 weeks
2.11 AUD
3.91 AUD
50 Day MA
3.62 AUD
Shares Short Prior Month
–
200 Day MA
2.84 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart